Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.
Clinical trial NCT02602249 · UNKNOWN
Trial details
- NCT number
- NCT02602249
- Sponsor
- Beijing Doing Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2019-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.